33
SCLERODERMA Virginia Steen, MD Professor of Medicine

SCLERODERMA Virginia Steen, MD Professor of Medicine

Embed Size (px)

Citation preview

Page 1: SCLERODERMA Virginia Steen, MD Professor of Medicine

SCLERODERMA

Virginia Steen, MD

Professor of Medicine

Page 2: SCLERODERMA Virginia Steen, MD Professor of Medicine

Scleroderma

• Localized Scleroderma–Morphea– Linear Scleroderma– En Coup de Sabre (Progressive

Hemi-atrophy)– Pansclerotic, Deep subcutaneous

Page 3: SCLERODERMA Virginia Steen, MD Professor of Medicine

Linear Scleroderma

Linear, single extremity

Hyperpigmented, Muscle atrophy

but normal strength

Page 4: SCLERODERMA Virginia Steen, MD Professor of Medicine

Linear Scleroderma

Severe contractures, growth disturbances, atrophy

Page 5: SCLERODERMA Virginia Steen, MD Professor of Medicine

Systemic Sclerosis

An uncommon disease 250/million population, 20 new cases/ million per year, about 80- 150,000 in US

Age onset usually 30-50 years, rare under 10.

Female 3-5: 1; Increased in African-Americans

Multisystem disease - Raynauds, digital ulcers, arthritis, tendon inflammation, skin thickening, myopathy, gastrointestinal, lung, heart and kidney involvement

Survival – decreased primarily from severe lung involvement, pulmonary fibrosis and pulmonary hypertension

Page 6: SCLERODERMA Virginia Steen, MD Professor of Medicine

Diagnosis

• Clinical diagnosis by Rheumatologist– Raynaud’s– Swollen fingers and/or skin thickening of

hands/face– Esophageal symptoms-GERD. – Other organs-

• Small intestines• Pulmonary Fibrosis• Pulmonary Hypertension• Cardiac or Kidney involvement

Page 7: SCLERODERMA Virginia Steen, MD Professor of Medicine

Laboratory Diagnosis

• Laboratory - not required– Antibodies helpful for prognosis, but not

necessary for diagnosis ( even ANA can be negative)

– There can be false positives, particularly slightly positive tests

– GI x-rays supportive but not required for diagnosis

Page 8: SCLERODERMA Virginia Steen, MD Professor of Medicine
Page 9: SCLERODERMA Virginia Steen, MD Professor of Medicine

Clinical features associated with limited and diffuse scleroderma

Limited cutaneous Diffuse cutaneous Raynaud’s -1st symptom, Raynaud’s often delayed

alone for many years Acute onset, a lot of

Milder general symptoms constitutional symptoms

Milder joint symptoms Arthralgias, carpal tunnel

Tendon friction rubs

Puffy FINGERsFINGERs Swollen, puffy HANDs HANDs Limited skin thickening Early diffuse skin

Anti-centromere antibody Anti-Scl 70 antibody

Anti-RNA polymerase III

Page 10: SCLERODERMA Virginia Steen, MD Professor of Medicine

SKI N

THICKNESS

50

40

30

20

10

0

DISEASE DURATION (YEARS)5 10 15 20

ContracturesRenal crisisMyocardial failure

Pulmonary hypertension Malabsorption

Limited sclerodermaLimited scleroderma

Pulmonary fibrosis

Diffuse sclerodermaDiffuse scleroderma

NATURAL HISTORY OF SCLERODERMA SUBSETS

Page 11: SCLERODERMA Virginia Steen, MD Professor of Medicine

RAYNAUD’S

Page 12: SCLERODERMA Virginia Steen, MD Professor of Medicine

Digital Ulcers

Page 13: SCLERODERMA Virginia Steen, MD Professor of Medicine

... and can lead to auto-amputation

Page 14: SCLERODERMA Virginia Steen, MD Professor of Medicine

Skin Thickening

Page 15: SCLERODERMA Virginia Steen, MD Professor of Medicine

Swollen Hands

Page 16: SCLERODERMA Virginia Steen, MD Professor of Medicine

Early Scleroderma Puffy Phase

Page 17: SCLERODERMA Virginia Steen, MD Professor of Medicine

Evaluation of Skin Thickening

Measuring skin thickness. Rodnan Skin Score

Rodnan Skin Score17 different sites-Score 0 to 3 Total 51Limited - <12Diffuse >12

Other Measures- Health Assessment Questionnaire Medsger Severity Scale (only research)

Page 18: SCLERODERMA Virginia Steen, MD Professor of Medicine

Joint and Tendon

• Hand swelling, joint pain and stiffness- fingers, wrists, swelling/puffiness, other joints also

• Contractures- hands, wrists, hips, shoulders, elbows.

• Acroosteolysis- deformity causing loss of function

• Tendon rubs- painful- hands, arms, ankles, knees

Page 19: SCLERODERMA Virginia Steen, MD Professor of Medicine

Sclerodactyly

Page 20: SCLERODERMA Virginia Steen, MD Professor of Medicine

Hand Contractures

Page 21: SCLERODERMA Virginia Steen, MD Professor of Medicine

CALCINOSIS

Page 22: SCLERODERMA Virginia Steen, MD Professor of Medicine

ACROOSTEOLYSIS

Page 23: SCLERODERMA Virginia Steen, MD Professor of Medicine
Page 24: SCLERODERMA Virginia Steen, MD Professor of Medicine

Systemic Sclerosis- Multisystem Disease

Page 25: SCLERODERMA Virginia Steen, MD Professor of Medicine

Gastrointestinal Involvement

• Esophageal- trouble swallowing, heartburn, reflux, potential aspiration

• Stomach –bloating, inability to eat full meals, need to eat small frequent meals

• Small Intestine- malabsorption, diarrhea, pseudo obstruction, bacterial overgrowth, weight loss, need for hyperalimentation.

• Large Intestine- constipation, rectal prolapse• Rectum- fecal incontinence

Page 26: SCLERODERMA Virginia Steen, MD Professor of Medicine

PULMONARY PROBLEMS IN SYSTEMIC SCLEROSIS

• Pleurisy, pleural effusions, pleural scarring• Spontaneous pneumothorax (bronchiectasis)• Aspiration pneumonia• Malignancy-all cell types• BOOP• Interstitial fibrosis• Pulmonary vascular disease (PHT)

Page 27: SCLERODERMA Virginia Steen, MD Professor of Medicine

Pulmonary Fibrosis

• Shortness of breath with activity

• Fatigue with activity

• Pulmonary function tests- Decreased FVC, TLC and DLCO, restrictive disease

• CT scan of lung- scarring, honeycombing

• Begins early in disease and progresses slowly or rapidly, major cause of death

Page 28: SCLERODERMA Virginia Steen, MD Professor of Medicine

Pulmonary Hypertension

• Shortness of breath and fatigue with exercise

• Occurs later in illness

• More common in limited scleroderma

• Low DLCO on PFTs, and high PAP on echo

• Most common cause of death

Page 29: SCLERODERMA Virginia Steen, MD Professor of Medicine

Heart and Kidney

• Less common but more serious

• Heart- Pericarditis, pericardial effusion, cardiomyopathy, rhythm

problems, heart failure

• Kidney- Malignant hypertension, kidney failure, dialysis.

Page 30: SCLERODERMA Virginia Steen, MD Professor of Medicine

Disability in Limited Scleroderma

– Usually after a long history of Raynaud’s, (unless digital ulcers)

– Pain, fatigue, GI symptoms– Loss of hand function – digital ulcers,

loss of mobility/dexterity, fine motion– Fatigue/shortness of breath- anemia,

weight loss, GI, pulmonary fibrosis/hypertension.

Page 31: SCLERODERMA Virginia Steen, MD Professor of Medicine

Special Situations

• Raynaud’s – can be disabling without ulcers, if job is outdoors, requires cold exposure (meat cutter)

• Limited skin- can be disabling even without contractures if very swollen, late acroosteolysis, need for fine motion

• GI –can be very disabling - with severe reflux, vomiting, difficulty swallowing, fatigue, inability to eat, weight loss

Page 32: SCLERODERMA Virginia Steen, MD Professor of Medicine

Disability in Diffuse Scleroderma

– Early in Disease- mostly from progressive skin thickening, pain, fatigue, weight loss, contractures, digital ulcers.

– Pulmonary fibrosis– Heart and Kidney

Page 33: SCLERODERMA Virginia Steen, MD Professor of Medicine

Special Consideration

• Most diffuse scleroderma patients have enough problems that they are disabled.

• While some diffuse scleroderma patients are able to continue working, it is usually because they are professionals and have a very flexible work situation.